Search Results

Pharm Country

Infinity BiologiX, Cytox, and Vanguard Pharma Announce the US Launch of the First, Physician Use Only, Polygenic Test to Predict the Risk of Cognitive Decline Due to Alzheimer’s Disease

Today, Infinity BiologiX, LLC (IBX), Cytox Ltd, and Vanguard Pharma announce the launch of the IBX Alzheimer’s Risk Test, powered by genoSCORE™. Physicians are able to pre-register to order the test, which will be available from early October 2021.

September 21, 2021

·

6 min read

Cytox Awarded New Innovate UK Funding for Alzheimer’s Testing

Cytox is pleased to announce that, in partnership with Cardiff University, the company has been awarded funding by Innovate UK.

March 8, 2018

·

1 min read

Business

Cytox Expands Collaboration with AIBL to Identify Those Most at Risk to Rapidly Progress to Alzheimer’s

Important research collaboration for pioneering PRS approach to help drug developers running clinical trials identify and stratify between slow and rapid progressors of the disease

September 24, 2018

·

2 min read

Cardiff University and Cytox to present further results on the implementation of SNPfitR analytical platform in identifying individuals for Alzheimer’s clinical trials at AD/PD conference in Lisbon

Study to show high accuracy of SNPfitR in predicting Alzheimer’s risk in both carriers and non-carriers of ApoE4

March 13, 2019

·

2 min read

Business

Cytox Launches Collaboration Agreement with Mayo Clinic to Evaluate Novel Genetic Based Approaches for Assessing Alzheimer’s Risk

Important research collaboration for pioneering PRS approach

May 22, 2018